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The evaluation of incidence of bone formation by whole syngeneic bone mar-
row cell suspension and by bone marrow stromal cell cultured in vitro injection 
into kidney parenchyma was done. Bone tissue was found in 26 kidneys out of 
100 injected with whole bone marrow cells suspension. Cultured stromal bone 
marrow cells grafted into kidney parenchyma produced ossicles in only 4 out of 
101 injected kidneys. Such low incidence of bone forming ability of the marrow 
stromal cell cultures grafted into kidney indicate their useless for study on bone 
histogenesis in the kidney by murine marrow stromal cell cultures. (Folia Morphol 
2014; 73, 4: 482–485)
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INTRODUCTION
In addition to haematopoietic cells which dif-
ferentiate into blood cells, bone marrow contains 
a stromal component, the complex of cells which 
provide the environment (a niche) for maintenance 
and differentiation of blood cell precursors.
Haematopoietic cells derive from the so called 
haematopoietic stem cell, a multipotent cell able to 
proliferate and differentiate into all types of blood 
circulating cells.
Stromal cells are derived from mesenchymal stem 
cells (MSC), which develop into a range of mesen-
chymal cells — fibroblasts, osteoblasts, adipocytes, 
chondrocytes and endothelial cells.
Although the interplay between the haemato-
poietic and stromal cells is well established [7, 15, 16], 
until recently no transition of cells from the hae-
matopoietic compartment into cells belonging to 
the stromal compartment were reported. More recent 
data, however, indicates the possibility of genera-
tion of some stromal cells, such as osteoblasts and 
adipocytes, from the haematopoietic compartment 
[17]. Thus, a new hypothesis postulating a common 
precursor cell for both haematopoietic and stromal 
compartments emerged [2, 5, 7, 17].
MSC were first isolated from bone marrow stromal 
cultures by Friedenstein (1976) [3], who described 
them as “mechanocytes”. These cells are able to dif-
ferentiate both in vivo and in vitro into osteogenic 
cells, thus are considered as osteoblast precursors 
and are widely used as osteogenic cells for tissue 
engineering purposes and for bone repair/healing. 
The bone marrow itself, as a rich source of osteopro-
genitors, or isolated bone marrow-derived stromal 
cells propagated in vitro are both used as a source 
of osteogenic cells for bone reconstruction [1, 8, 11].
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In this communication paper a comparison of bone 
formation in the mouse kidneys by syngeneic 
whole bone marrow cell suspension and by 
a suspension of bone cultured marrow stromal cells 
was undertaken.
MATERIALS AND METHODS
Animals and treatment
Three-month old female syngeneic Balb/c mice 
weighing 25–30 g, bread in the animal room of the 
Chair and Department of Histology and Embryology of 
our University, were used in accordance with the Me-
dical University of Warsaw guidelines for the care and 
use of laboratory animals (permission no. 54 of Ethical 
Committee granted to Dr Ryszard Galus). Institutional 
guidelines for the care and treatment of laboratory 
animals were observed. The mice were kept up to 
8 per cage with free access to mouse chow and water. 
For surgery mice were anaesthetised with an intrape-
ritoneal injection of 0.15 mL of 0.36% chlorohydrate. 
Animals were sacrificed by cervical dislocation.
Collection of bone marrow cells
Bone marrow cells were flushed out from femoral 
cavities by syringing with minimal essential medium 
(MEM, Gibco, UK). Pooled marrow from several ani-
mals was centrifuged and the cell suspension was 
used either immediately for transplantation into the 
kidneys or for stromal cell culture for later use.
For freshly-harvested marrow cells, the contents 
of 2 femoral cavities (ca 10 × 106 of nucleated cells) 
were suspended in 0.5 mL of MEM and injected in 
0.1–0.15 mL into the surgically exposed right kidney 
of experimental mice, each mice therefore receiving 
2–3 × 106 cells.
Stromal cell culture
The bone marrow cell suspension was cultured in 
Falcon plastic flasks (Corning Life Sciences, USA) in 
the MEM supplemented with foetal calf serum and 
antibiotics (Penicillin/Streptomycin, PAA laboratories 
GmbH, Austria). Two–four days later the medium was 
replenished and flask-adherent stromal cells were 
cultured for a further 8 to 30 days. Cells were trypsi-
nised with 0.25% trypsin solution (Gibco, Scotland) 
and detached with a rubber scraper, washed in pho-
sphate-buffered saline and ca 1 million of cells were 
injected into surgically exposed kidney. The viability 
of cells was ca 80%, as estimated by the trypan blue 
exclusion test.
The efficiency of the graft cell response was deter-
mined by the presence of bone in the kidney exami-
ned histologically. For the analysis paraffin-embedded 
10 µm serial sections were stained with haematoxylin 
and eosin.
Statistical analysis
SPSS 19 software (IBM SPSS Statistics, Armonk, 
NY, USA) was used for statistical data processing. The 
comparison of the incidence of bone formation by 
whole bone marrow and by stromal cells grafting was 
evaluated by analysis of 95% confidence interval (CI).
RESULTS
The numbers of grafts performed and the inci- 
dence of bone formation following short term 
(8–10 days) and long-term (15–30 days) stromal cul-
ture administration are presented in the Table 1.
Administration of whole bone marrow cell suspen-
sion into kidney parenchyma of syngeneic recipient 
mice as evaluated 10–15 days post grafting or 16–30 days 
post grafting gave similar results. The incidence 
Table 1. The incidence of bone formation in the kidney parenchyma following injection of syngeneic whole bone marrow cell suspen-
sion and of cultured bone marrow-derived stromal cells
Injected cells Duration of experiment  
[days]
No. of kidneys 
injected
No. of kidneys with bone  
ossicles (% of bone incidence)
Whole bone marrow cell suspension 10–15
16–30
27
71
6 (22.2%)
18 (25.4%)
Total 100 26 (26%)*
Stromal cells cultured for:
8–10 days 11–20 83 4 (4.8%)
11–20 days 11–20 18 0 (0%)
Total 101 4 (4%)*
*Statistically significant difference of bone incidence at 95% confidence interval
484
Folia Morphol., 2014, Vol. 73, No. 4
of bone formation was lower than expected, reaching 
25% of cases (Table 1). In all instances bone trabeculae 
were formed by intramembranous ossification, with- 
out any cartilage formation. Bone trabeculae were 
usually covered by osteoblasts, but bone marrow 
was observed inside ectopic bone only in 3 out of 18 
cases of older bone (Fig. 1) 
Surprisingly, injection of cultured stromal cells 
resulted in a markedly lower incidence of bone for-
mation than followed administration of whole mar-
row cell suspension. In only 4 out of 101 implanted 
mice was the evidence of renal osteogenesis. Further- 
more, osteogenesis occurred exclusively follo-
wing injection of cells from short-term (5–8 days) 
stromal cultures. In a group of stromal cells cultured 
longer, for 15–20 days, no bone formation was ob-
served (Table 1).
The differences of bone incidence between whole 
bone marrow vs. stromal cells was statistically signifi-
cant at 95% of CI (incidence 0.26, 95% CI 0.174–0.346 
vs. incidence 0.04; 95% CI 0.001–0.078) (Fig. 1).
DISCUSSION
The incidence of formation of bone following 
implantation of whole bone marrow cell suspension 
into kidney parenchyma by the technique used here 
was rather low. The reason for it could be leaking of 
grafted cells from the kidney during manipulation 
(insertion) of exposed kidney to locate it back into 
abdominal cavity or during presence there. The num-
ber of injected cells exceeded the minimum known to 
initiate osteogenesis in the muscles [9, 14].
One can consider that the extent of bone in hete-
rotopic transplants of marrow stromal cells increases 
with increased mesenchymal stem cell number, and 
a threshold number of MSC is necessary for bone 
formation. A high local threshold density of bone 
marrow stromal cells is needed for formation of bone [9]. 
The need of sufficient bone marrow concentration 
to trigger bone formation was earlier reported also 
by Tavassoli et al. (1971) [14].
The protocol of MSC cultures applied in our exper-
iment could, at least in part, explain the low incidence 
of bone formation. We have cultured stromal cells in 
standard medium on plastic. Expansion of MSC on 
conventional tissue culture plastic attenuates in vitro 
osteogenic differentiation and in vivo osteogenesis. 
To maintain osteogenic differentiation potential, the 
MSC should be propagated on collagen matrix [10].
Another reason for a poor osteogenic capability 
of marrow stromal cells grafted into the kidney co-
uld be the lack of added osteogenic differentiation 
factors to the culture medium, such as PTH, TGF-B, 
BMP, vitamin D. Such conditioning distinct increases 
differentiation [4, 12, 13].
In contrast to low bone incidence by syngeneic 
bone marrow stromal cell cultures, Krebsbach et al. 
(1997) [6] reported consistently formation of capsule 
of cortical-like bone surrounding a cavity with active 
haematopoiesis in immunodeficient mice following 
subcutaneous transplantation of marrow stromal 
fibroblast loaded into gelatin, polyvinyl sponges and 
collagen matrices. Likely the procedure applied by 
them prevented the loss of grafted cells from implant 
bed [6].
Nevertheless, the primary bone marrow stromal 
cell culture was greatly inferior to freshly-isolated 
whole bone marrow in osteoinduction. Whole bone 
marrow cell suspension on introduction into kidney 
parenchyma resulted with bone formation in only 
25% of mice, a value less than expected, and as 
was reported by others on subcutaneously implanted 
bone marrow cells [6].
The technique of bone marrow stromal cell cul-
ture applied in this experiment was simple and the 
tissue culture medium was not fortified by osteotropic 
agents.
To our knowledge, this is the first report on os-
teogenesis incidence by freshly-isolated bone mar-
row cells and by marrow stromal cell cultures in the 
mouse kidney.
Figure 1. Bone formation in the kidney following subcapsular injec-
tion of syngeneic whole bone marrow cell suspension; haematoxy-
lin-eosin staining, scale bar: 50 µm.
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The results presented in this paper indicate for 
a limited utility of intrarenal administration of presu-
mably osteogenic cells for the examination of their 
bone-forming capability in mice. Low incidence of 
osteogenesis in the applied model could be in part 
explained by improper ratio of the volume of cell 
suspension to the volume of the injected kidney and 
thus by leaking of grafted cells from kidney, so the 
critical cell density is not achieved.
CONCLUSIONS
In mice, the technique of intrarenal administration 
of syngeneic bone marrow cells for in vivo evaluation 
of their osteogenic potency is not reliable as the in-
cidence of bone formation in this model is low, nor 
exceeding 25%.
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